It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Fusobacterium necrophorum is a Gram-negative anaerobic bacterium responsible for localized infections of the oropharynx that can evolve into bacteremia and/or septic thrombophlebitis of the jugular vein or peritonsillar vein, called Lemierre’s syndrome. To identify microbial genetic determinants associated with the severity of this life-threatening disease, 70 F. necrophorum strains were collected and grouped into two categories according to the clinical presentation: (i) localized infection, (ii) bacteremia with/without Lemierre’s syndrome. Comparative genomic analyses revealed two clades with distinct genetic content, one clade being significantly enriched with isolates from subjects with bacteremia. To identify genetic determinants contributing to F. necrophorum pathogenicity, genomic islands and virulence factor orthogroups (OVFs) were predicted. The presence/absence profiles of OVFs did not group isolates according to their clinical category, but rather according to their phylogeny. However, a variant of lktA, a key virulence factor, with a frameshift deletion that results in two open reading frames, was associated with bacteremia. Moreover, a genome-wide association study identified three orthogroups associated with bacteremic strains: (i) cas8a1, (ii) a sodium/solute symporter, and (iii) a POP1 domain-containing protein. Further studies must be performed to assess the functional impact of lktA mutation and of these orthogroups on the physiopathological mechanisms of F. necrophorum infections.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Lausanne University Hospital and University of Lausanne, Institute of Microbiology, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204)
2 Lausanne University Hospital, Service of Infectious Diseases, Department of Medicine, Lausanne, Switzerland (GRID:grid.8515.9) (ISNI:0000 0001 0423 4662)
3 University Hospital of Geneva, Service of Bacteriology and Infectious Diseases, Department of Medicine, Geneva, Switzerland (GRID:grid.150338.c) (ISNI:0000 0001 0721 9812)
4 Lausanne University Hospital and University of Lausanne, Institute of Microbiology, Lausanne, Switzerland (GRID:grid.9851.5) (ISNI:0000 0001 2165 4204); Lausanne University Hospital, Service of Infectious Diseases, Department of Medicine, Lausanne, Switzerland (GRID:grid.8515.9) (ISNI:0000 0001 0423 4662)